{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:24:49Z","timestamp":1787498689193,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jaac.2014.12.015","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T09:00:43Z","timestamp":1422608443000},"page":"180-190","source":"Crossref","is-referenced-by-count":63,"title":["Child\/Adolescent Anxiety Multimodal Study: Evaluating\u00a0Safety"],"prefix":"10.1016","volume":"54","author":[{"given":"Moira A.","family":"Rynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Walkup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott N.","family":"Compton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara J.","family":"Sakolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel T.","family":"Sherrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Piacentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Keeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Waslick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Chrisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Birmaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2014.12.015_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.psc.2009.06.002","article-title":"Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V","volume":"32","author":"Beesdo","year":"2009","journal-title":"Psychiatr Clin N Am"},{"key":"10.1016\/j.jaac.2014.12.015_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.chc.2005.06.003","article-title":"The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity","volume":"14","author":"Costello","year":"2005","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jaac.2014.12.015_bib3","series-title":"Learned Helplessness, Anxiety, and Achievement Motivation: Neglected Parallels in Cognitive, Affective, and Coping Responses. Series in Clinical and Community Psychology: Achievement, Stress, and Anxiety","first-page":"93","author":"Dweck","year":"1982"},{"key":"10.1016\/j.jaac.2014.12.015_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1207\/s15374424jccp1802_10","article-title":"Multimethod assessment of the social competence of children with anxiety disorders","volume":"18","author":"Strauss","year":"1989","journal-title":"J\u00a0Clin Child Psychol"},{"key":"10.1016\/j.jaac.2014.12.015_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1037\/0022-006X.72.2.276","article-title":"Child anxiety treatment: outcomes in adolescence and impact on substance use and depression at 7.4-year follow-up","volume":"72","author":"Kendall","year":"2004","journal-title":"J\u00a0Consult Clin Psychol"},{"key":"10.1016\/j.jaac.2014.12.015_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archpsyc.55.1.56","article-title":"The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders","volume":"55","author":"Pine","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2014.12.015_bib7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.chi.0000127589.57468.bf","article-title":"Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review","volume":"43","author":"Compton","year":"2004","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.12.015_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/15374416.2012.632352","article-title":"No need to worry: the promising future of child anxiety research","volume":"41","author":"Kendall","year":"2012","journal-title":"J\u00a0Clin Child Adolesc Psychol"},{"key":"10.1016\/j.jaac.2014.12.015_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.chc.2012.05.007","article-title":"Targeting parental psychopathology in child anxiety","volume":"21","author":"Vidair","year":"2012","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jaac.2014.12.015_bib10","first-page":"CD005170","article-title":"Pharmacotherapy for anxiety disorders in children and adolescents","author":"Ipser","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaac.2014.12.015_bib11","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM200104263441703","article-title":"Fluvoxamine for the treatment of anxiety disorders in children and adolescents","volume":"344","author":"Pine","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2014.12.015_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/da.20769","article-title":"Advances in pharmacotherapy for pediatric anxiety disorders","volume":"28","author":"Rynn","year":"2011","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jaac.2014.12.015_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1056-4993(18)30138-X","article-title":"Pharmacologic treatment of anxiety disorders in children and adolescents","volume":"9","author":"Velosa","year":"2000","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jaac.2014.12.015_bib14","unstructured":"Strawn JR, Prakash A, Zhang Q, et\u00a0al. A randomized, placebo-controlled study of duloxetine for the treatment of children (7-11 years) and adolescents (12-17 years) with generalized anxiety disorder. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, October 22-27, 2013, Orlando, FL."},{"key":"10.1016\/j.jaac.2014.12.015_bib15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.CHI.0000037049.04952.9F","article-title":"Fluoxetine for the treatment of childhood anxiety disorders","volume":"42","author":"Birmaher","year":"2003","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.12.015_bib16","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.280.20.1752","article-title":"Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial","volume":"280","author":"March","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2014.12.015_bib17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.290.8.1033","article-title":"Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials","volume":"290","author":"Wagner","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2014.12.015_bib18","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","article-title":"Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety","volume":"359","author":"Walkup","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2014.12.015_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/cap.2006.16.159","article-title":"Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents","volume":"16","author":"Safer","year":"2006","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2014.12.015_bib20","unstructured":"Hammad TA. Review and Evaluation of Clinical Data: Relationship between psychotropic drugs and pediatric suicidality. US Food and Drug Administration website. 2004. Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/briefing\/2004-4065b1-10-TAB08-Hammads-Review.pdf. Accessed December 8,\u00a02014."},{"key":"10.1016\/j.jaac.2014.12.015_bib21","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","article-title":"Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials","volume":"297","author":"Bridge","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2014.12.015_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chc.2005.08.007","article-title":"Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents","volume":"15","author":"Correll","year":"2006","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jaac.2014.12.015_bib23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00004583-200205000-00008","article-title":"National trends in the use of psychotropic medications by children","volume":"41","author":"Olfson","year":"2002","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.12.015_bib24","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/01.chi.0000142668.29191.13","article-title":"Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology","volume":"43","author":"Greenhill","year":"2004","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.12.015_bib25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.283.8.1025","article-title":"Trends in the prescribing of psychotropic medications to preschoolers","volume":"283","author":"Zito","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2014.12.015_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.292.7.807","article-title":"Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) Randomized controlled trial","volume":"292","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2014.12.015_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1753-2000-4-1","article-title":"Child\/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods","volume":"4","author":"Compton","year":"2010","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"10.1016\/j.jaac.2014.12.015_bib28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.janxdis.2010.01.009","article-title":"Clinical characteristics of anxiety disordered youth","volume":"24","author":"Kendall","year":"2010","journal-title":"J\u00a0Anxiety Disord"},{"key":"10.1016\/j.jaac.2014.12.015_bib29","series-title":"The ECDEU Assessment Manual for Psychopharmacology\u2013Revised","author":"Guy","year":"1976"},{"key":"10.1016\/j.jaac.2014.12.015_bib30","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/01.chi.0000138356.29099.f1","article-title":"Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial","volume":"43","author":"Geller","year":"2004","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.12.015_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1753-2000-2-11","article-title":"Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit\/hyperactivity disorder: findings from a patient, parent and physician perspective using items from the Pediatric Adverse Event Rating Scale (PAERS)","volume":"2","author":"Wehmeier","year":"2008","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"10.1016\/j.jaac.2014.12.015_bib32","unstructured":"Fisher PW, Lake AM, Hundt SR, et\u00a0al. Columbia Health and Adverse Reactions to Medication Screen (CHARMS): a computerized measure for identifying possible adverse events. Poster presented at the 57th Annual Meeting of the American Academy of Child and Adolecent Psychiatry, October 26-31, 2010, New York, NY."},{"key":"10.1016\/j.jaac.2014.12.015_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/08039480802315673","article-title":"Issues in the dissemination of cognitive-behavior therapy","volume":"62","author":"Taylor","year":"2008","journal-title":"Nord J Psychiatry"},{"key":"10.1016\/j.jaac.2014.12.015_bib34","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial","volume":"292","year":"2004","journal-title":"JAMA"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856714008946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856714008946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T06:19:50Z","timestamp":1566281990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856714008946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0890856714008946"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2014.12.015","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}